AstraZeneca PLC (AZN)

NYQ – Real Time Price. Currency in USD

158.56

-0.19 (-0.12%)

Market open: Aug 12, 2026, 1:10 PM EDT

158.80

+0.05 (0.03%)

Previous after-hours: Aug 11, 2026, 7:52 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

60.05B

52.94B

46.91B

43.55B

Cost of goods sold

-15.22B

-13.25B

-12.22B

-15.95B

Gross Profit

44.82B

39.70B

34.69B

27.59B

Operating expenses (excl. COGS)

-30.50B

-27.18B

-25.06B

-22.62B

Operating Income

14.32B

12.52B

9.64B

4.97B

Non-operating income, total

-1.63B

-3.98B

-2.56B

-2.51B

Pretax income

12.68B

8.54B

7.08B

2.46B

Equity in earnings

-7M

-27M

-12M

-5M

Taxes

-2.22B

-1.62B

-961M

778M

Non-controlling/minority interest

-8M

-6M

-5M

After tax other income/expense

Net income before discontinued operations

10.45B

6.89B

6.10B

3.23B

Discontinued operations

Net income

10.45B

6.89B

6.10B

3.23B

Dilution adjustment

Preferred dividends

AstraZeneca PLC (AZN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AstraZeneca PLC (AZN)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

AstraZeneca PLC (AZN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AstraZeneca PLC (AZN)

Income Statement (Annual)

Income Statement (Annual)